0.5
Cite Score
SJR: 0.129 / SNIP: 0.140
JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
Volume 17, Issue 2 (2025)
3 2025, 17(2): 191-196 |
Back to browse issues page
Ethics code: INTI-FHLS-03-01-2021
History
Received: 2025/03/18 | Accepted: 2025/06/18 | Published: 2025/06/28
Received: 2025/03/18 | Accepted: 2025/06/18 | Published: 2025/06/28
How to cite this article
Alhnon F, Hassan F. Impact of Chemotherapy on Antioxidant Vitamins in Lymphoid Cancer. 3 2025; 17 (2) :191-196
URL: http://ijwph.daneshafarand.org/article-3-85628-en.html
URL: http://ijwph.daneshafarand.org/article-3-85628-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Department of Chemistry, College of Science, Al-Nahrain University, Baghdad, Iraq
Abstract (1064 Views)
Aims: Lymphoid malignancies are increasingly prevalent in Iraq, where chemotherapy remains the principal treatment despite its association with oxidative stress. This study investigated the impact of chemotherapy on serum levels of antioxidant vitamins C, E, and D3 in patients with lymphoma.
Materials & Methods: This case-control study was conducted involving 120 individuals divided into three groups, including healthy controls (n=40), newly diagnosed untreated lymphoma patients (n=40), and lymphoma patients undergoing chemotherapy (n=40). Serum levels of vitamins C, E, and D3 were measured using ELISA, and statistical analysis was performed using ANOVA followed by Tukey’s post hoc analysis. The diagnostic potential was assessed through receiver operating characteristic curve analysis.
Findings: All lymphoma patients exhibited significantly reduced serum concentrations of vitamins C, E, and D3 compared to controls (p<0.0001). Chemotherapy-treated patients showed partial recovery in these levels, although the values remained below normal. Receiver operating characteristic analysis revealed strong discriminatory power for all three vitamins, especially vitamin D3, which emerged as a promising biomarker for disease presence and treatment monitoring.
Conclusion: Chemotherapy in lymphoma patients leads to partial improvement, but not normalization, of antioxidant vitamin levels.
Materials & Methods: This case-control study was conducted involving 120 individuals divided into three groups, including healthy controls (n=40), newly diagnosed untreated lymphoma patients (n=40), and lymphoma patients undergoing chemotherapy (n=40). Serum levels of vitamins C, E, and D3 were measured using ELISA, and statistical analysis was performed using ANOVA followed by Tukey’s post hoc analysis. The diagnostic potential was assessed through receiver operating characteristic curve analysis.
Findings: All lymphoma patients exhibited significantly reduced serum concentrations of vitamins C, E, and D3 compared to controls (p<0.0001). Chemotherapy-treated patients showed partial recovery in these levels, although the values remained below normal. Receiver operating characteristic analysis revealed strong discriminatory power for all three vitamins, especially vitamin D3, which emerged as a promising biomarker for disease presence and treatment monitoring.
Conclusion: Chemotherapy in lymphoma patients leads to partial improvement, but not normalization, of antioxidant vitamin levels.
Keywords: